| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | COVER ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
||||||||
|
||||||||||
Dr. Parkin is Chief, Unit of Descriptive Epidemiology, International Agency for Research on Cancer, Lyon, France.
Mr. Bray is Epidemiologist, Unit of Descriptive Epidemiology, International Agency for Research on Cancer, Lyon, France.
Mr. Ferlay is Informatics Officer, Unit of Descriptive Epidemiology, International Agency for Research on Cancer, Lyon, France.
Dr. Pisani is Scientist, Unit of Descriptive Epidemiology, International Agency for Research on Cancer, Lyon, France.
Estimates of the worldwide incidence, mortality and prevalence of 26 cancers in the year 2002 are now available in the GLOBOCAN series of the International Agency for Research on Cancer. The results are presented here in summary form, including the geographic variation between 20 large "areas" of the world. Overall, there were 10.9 million new cases, 6.7 million deaths, and 24.6 million persons alive with cancer (within three years of diagnosis). The most commonly diagnosed cancers are lung (1.35 million), breast (1.15 million), and colorectal (1 million); the most common causes of cancer death are lung cancer (1.18 million deaths), stomach cancer (700,000 deaths), and liver cancer (598,000 deaths). The most prevalent cancer in the world is breast cancer (4.4 million survivors up to 5 years following diagnosis). There are striking variations in the risk of different cancers by geographic area. Most of the international variation is due to exposure to known or suspected risk factors related to lifestyle or environment, and provides a clear challenge to prevention.
This article has been cited by other articles:
|
|
 |
|
  Y. Yang, M.-P. Tetreault, Y. A. Yermolina, B. G. Goldstein, and J. P. Katz Kruppel-like Factor 5 Controls Keratinocyte Migration via the Integrin-linked Kinase J. Biol. Chem., July 4, 2008; 283(27): 18812 - 18820. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. J. Maloney and M. A. Weinberg A Comprehensive Analysis of Babe Ruth's Head and Neck Cancer J Am Dent Assoc, July 1, 2008; 139(7): 926 - 932. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Campos, C. Prior, F. Warleta, I. Zudaire, J. Ruiz-Mora, R. Catena, A. Calvo, and J. J. Gaforio Phenotypic and Genetic Characterization of Circulating Tumor Cells by Combining Immunomagnetic Selection and FICTION Techniques J. Histochem. Cytochem., July 1, 2008; 56(7): 667 - 675. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Sasaki, T. Nakamura, R. B. Rebhun, H. Cheng, K. S. Hale, R. Z. Tsan, I. J. Fidler, and R. R. Langley Modification of the Primary Tumor Microenvironment by Transforming Growth Factor {alpha}-Epidermal Growth Factor Receptor Signaling Promotes Metastasis in an Orthotopic Colon Cancer Model Am. J. Pathol., July 1, 2008; 173(1): 205 - 216. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. J. Chua and J. R. Zalcberg Pancreatic cancer--is the wall crumbling? Ann. Onc., July 1, 2008; 19(7): 1224 - 1230. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. L. Gomez, D. C. Doval, M. A. Chavez, P. C.-S. Ang, Z. Aziz, S. Nag, C. Ng, S. X. Franco, L. W.C. Chow, M. C. Arbushites, et al. Efficacy and Safety of Lapatinib As First-Line Therapy for ErbB2-Amplified Locally Advanced or Metastatic Breast Cancer J. Clin. Oncol., June 20, 2008; 26(18): 2999 - 3005. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Sinha, S. Devesa, T. Rastogi, and A. Mathew Author's response Int. J. Epidemiol., June 20, 2008; (2008) dyn120v1. [Full Text] [PDF]
|
|
|
|
 |
|
 I. Soerjomataram, W. J. Louwman, V. E. P. P. Lemmens, J. W. W. Coebergh, and E. de Vries Are Patients with Skin Cancer at Lower Risk of Developing Colorectal or Breast Cancer? Am. J. Epidemiol., June 15, 2008; 167(12): 1421 - 1429. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. D. Peacock and D. N. Watkins Cancer Stem Cells and the Ontogeny of Lung Cancer J. Clin. Oncol., June 10, 2008; 26(17): 2883 - 2889. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Ohno, H. Koyama, Y. Onishi, D. Takenaka, M. Nogami, T. Yoshikawa, S. Matsumoto, Y. Kotani, and K. Sugimura Non-Small Cell Lung Cancer: Whole-Body MR Examination for M-Stage Assessment--Utility for Whole-Body Diffusion-weighted Imaging Compared with Integrated FDG PET/CT Radiology, June 6, 2008; (2008) 2482072039. [Abstract] [Full Text]
|
|
|
|
 |
|
 B. Pasche Familial Colorectal Cancer: A Genetics Treasure Trove for Medical Discovery JAMA, June 4, 2008; 299(21): 2564 - 2565. [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Hammoud, B. Tan, S. Badve, and R. M Bigsby Estrogen promotes tumor progression in a genetically defined mouse model of lung adenocarcinoma Endocr. Relat. Cancer, June 1, 2008; 15(2): 475 - 483. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D Bonofiglio, H Qi, S Gabriele, S Catalano, S Aquila, M Belmonte, and S Ando Peroxisome proliferator-activated receptor {gamma} inhibits follicular and anaplastic thyroid carcinoma cells growth by upregulating p21Cip1/WAF1 gene in a Sp1-dependent manner Endocr. Relat. Cancer, June 1, 2008; 15(2): 545 - 557. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-C. Chuang, M. Hashibe, G. Scelo, D. H. Brewster, E. Pukkala, S. Friis, E. Tracey, E. Weiderpass, K. Hemminki, S. Tamaro, et al. Risk of Second Primary Cancer among Esophageal Cancer Patients: a Pooled Analysis of 13 Cancer Registries Cancer Epidemiol. Biomarkers Prev., June 1, 2008; 17(6): 1543 - 1549. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. W. Ryu, Y.-W. Kim, J. H. Lee, B.-H. Nam, M.-C. Kook, I. J. Choi, and J.-M. Bae Surgical Complications and the Risk Factors of Laparoscopy-Assisted Distal Gastrectomy in Early Gastric Cancer Ann. Surg. Oncol., June 1, 2008; 15(6): 1625 - 1631. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. W. Wilkinson, J. Howe, G. Gay, L. Patel-Parekh, C. Scott-Conner, and J. Donohue Differences in the Pattern of Presentation and Treatment of Proximal and Distal Gastric Cancer: Results of the 2001 Gastric Patient Care Evaluation Ann. Surg. Oncol., June 1, 2008; 15(6): 1644 - 1650. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. Moriarty and J. E. Stryker Prevention and screening efficacy messages in newspaper accounts of cancer Health Educ. Res., June 1, 2008; 23(3): 487 - 498. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Hegarty, M. Wallace, and H. Comber Uncertainty and Quality of Life Among Men Undergoing Active Surveillance for Prostate Cancer in the United States and Ireland American Journal of Men's Health, June 1, 2008; 2(2): 133 - 142. [Abstract] [PDF]
|
|
|
|
 |
|
 W. I. Jang, H.-G. Wu, C. I. Park, K. H. Kim, M.-W. Sung, M.-J. Kim, P.-H. Choung, J.-H. Lee, and J.-Y. Choi Treatment of Patients with Clinically Lymph Node-negative Squamous Cell Carcinoma of the Oral Cavity Jpn. J. Clin. Oncol., June 1, 2008; 38(6): 395 - 401. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Thones, A. Herreiner, L. Schadlich, K. Piuko, and M. Muller A Direct Comparison of Human Papillomavirus Type 16 L1 Particles Reveals a Lower Immunogenicity of Capsomeres than Viruslike Particles with Respect to the Induced Antibody Response J. Virol., June 1, 2008; 82(11): 5472 - 5485. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. F. Aykan and E. Idelevich The role of UFT in advanced gastric cancer Ann. Onc., June 1, 2008; 19(6): 1045 - 1052. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Beane, P. Sebastiani, T. H. Whitfield, K. Steiling, Y.-M. Dumas, M. E. Lenburg, and A. Spira A Prediction Model for Lung Cancer Diagnosis that Integrates Genomic and Clinical Features Cancer Prevention Research, June 1, 2008; 1(1): 56 - 64. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Wang, Z. Zhang, H. Zhu, G. Fu, S. Wang, D. Wu, J. Zhou, Q. Wei, and Z. Zhang A Novel Functional Polymorphism C1797G in the MDM2 Promoter Is Associated with Risk of Bladder Cancer in a Chinese Population Clin. Cancer Res., June 1, 2008; 14(11): 3633 - 3640. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V S Bennett, M Varma, and D M Bailey Guidelines for the macroscopic processing of radical prostatectomy and pelvic lymphadenectomy specimens J. Clin. Pathol., June 1, 2008; 61(6): 713 - 721. [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Llovet, A. M. Di Bisceglie, J. Bruix, B. S. Kramer, R. Lencioni, A. X. Zhu, M. Sherman, M. Schwartz, M. Lotze, J. Talwalkar, et al. Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma J Natl Cancer Inst, May 21, 2008; 100(10): 698 - 711. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Matsubara, Y. Yamada, Y. Hirashima, D. Takahari, N. T. Okita, K. Kato, T. Hamaguchi, K. Shirao, Y. Shimada, and T. Shimoda Impact of Insulin-Like Growth Factor Type 1 Receptor, Epidermal Growth Factor Receptor, and HER2 Expressions on Outcomes of Patients with Gastric Cancer Clin. Cancer Res., May 15, 2008; 14(10): 3022 - 3029. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Wang, A. T. C. Lee, J. Z. I. Ma, J. Wang, J. Ren, Y. Yang, E. Tantoso, K.-B. Li, L. L. P. J Ooi, P. Tan, et al. Profiling MicroRNA Expression in Hepatocellular Carcinoma Reveals MicroRNA-224 Up-regulation and Apoptosis Inhibitor-5 as a MicroRNA-224-specific Target J. Biol. Chem., May 9, 2008; 283(19): 13205 - 13215. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Andrae, L. Kemetli, P. Sparen, L. Silfverdal, B. Strander, W. Ryd, J. Dillner, and S. Tornberg Screening-Preventable Cervical Cancer Risks: Evidence From a Nationwide Audit in Sweden J Natl Cancer Inst, May 7, 2008; 100(9): 622 - 629. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. L Crowe, T. J Key, P. N Appleby, R. C Travis, K. Overvad, M. U Jakobsen, N. F Johnsen, A. Tjonneland, J. Linseisen, S. Rohrmann, et al. Dietary fat intake and risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition Am. J. Clinical Nutrition, May 1, 2008; 87(5): 1405 - 1413. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. E. Pories, D. Zurakowski, R. Roy, C. C. Lamb, S. Raza, A. Exarhopoulos, R. G. Scheib, S. Schumer, C. Lenahan, V. Borges, et al. Urinary Metalloproteinases: Noninvasive Biomarkers for Breast Cancer Risk Assessment Cancer Epidemiol. Biomarkers Prev., May 1, 2008; 17(5): 1034 - 1042. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Sauter, A. Rosenberger, L. Beckmann, S. Kropp, K. Mittelstrass, M. Timofeeva, G. Wolke, A. Steinwachs, D. Scheiner, E. Meese, et al. Matrix Metalloproteinase 1 (MMP1) Is Associated with Early-Onset Lung Cancer Cancer Epidemiol. Biomarkers Prev., May 1, 2008; 17(5): 1127 - 1135. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Leeming, A. Hegele, I. Byrjalsen, R. Hofmann, P. Qvist, M. A. Karsdal, A. J. Schrader, R. Wagner, and P. Olbert Biochemical Markers for Monitoring Response to Therapy: Evidence for Higher Bone Specificity by a Novel Marker Compared with Routine Markers Cancer Epidemiol. Biomarkers Prev., May 1, 2008; 17(5): 1269 - 1276. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Dahl, M. Karlsson, P. Marits, A. Hoffstedt, O. Winqvist, and M. Thorn Metinel Node--The First Lymph Node Draining a Metastasis--Contains Tumor-Reactive Lymphocytes Ann. Surg. Oncol., May 1, 2008; 15(5): 1454 - 1463. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. F. Lai, S. Kim, C. Li, S. J. Oh, W. J. Hyung, W. H. Choi, S. H. Choi, L. B. Wang, and S. H. Noh Clinicopathologic Characteristics and Prognosis for Young Gastric Adenocarcinoma Patients after Curative Resection Ann. Surg. Oncol., May 1, 2008; 15(5): 1464 - 1469. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Ito, Y. Shimada, T. Kan, S. David, Y. Cheng, Y. Mori, R. Agarwal, B. Paun, Z. Jin, A. Olaru, et al. Pituitary Tumor-Transforming 1 Increases Cell Motility and Promotes Lymph Node Metastasis in Esophageal Squamous Cell Carcinoma Cancer Res., May 1, 2008; 68(9): 3214 - 3224. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. Madeleine, L. G. Johnson, A. G. Smith, J. A. Hansen, B. B. Nisperos, S. Li, L.-P. Zhao, J. R. Daling, S. M. Schwartz, and D. A. Galloway Comprehensive Analysis of HLA-A, HLA-B, HLA-C, HLA-DRB1, and HLA-DQB1 Loci and Squamous Cell Cervical Cancer Risk Cancer Res., May 1, 2008; 68(9): 3532 - 3539. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. B. Liao, J. Publicover, J. K. Rose, and D. DiMaio Single-Dose, Therapeutic Vaccination of Mice with Vesicular Stomatitis Virus Expressing Human Papillomavirus Type 16 E7 Protein Clin. Vaccine Immunol., May 1, 2008; 15(5): 817 - 824. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-H. Kohne, J. De Greve, J. T. Hartmann, I. Lang, P. Vergauwe, K. Becker, D. Braumann, E. Joosens, L. Muller, J. Janssens, et al. Irinotecan combined with infusional 5-fluorouracil/folinic acid or capecitabine plus celecoxib or placebo in the first-line treatment of patients with metastatic colorectal cancer. EORTC study 40015 Ann. Onc., May 1, 2008; 19(5): 920 - 926. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Persson, S. Sasazuki, M. Inoue, N. Kurahashi, M. Iwasaki, T. Miura, W. Ye, S. Tsugane, and for the JPHC Study Group Plasma levels of carotenoids, retinol and tocopherol and the risk of gastric cancer in Japan: a nested case-control study Carcinogenesis, May 1, 2008; 29(5): 1042 - 1048. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Miyamoto, Y. Yasui, T. Tanaka, H. Ohigashi, and A. Murakami Suppressive effects of nobiletin on hyperleptinemia and colitis-related colon carcinogenesis in male ICR mice Carcinogenesis, May 1, 2008; 29(5): 1057 - 1063. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Arnold, T. Hohler, C. Dittrich, F. Lordick, T. Seufferlein, J. Riemann, E. Woll, T. Herrmann, A. Zubel, and H.-J. Schmoll Cetuximab in combination with weekly 5-fluorouracil/folinic acid and oxaliplatin (FUFOX) in untreated patients with advanced colorectal cancer: a phase Ib/II study of the AIO GI Group Ann. Onc., April 25, 2008; (2008) mdn150v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-C. Wang, S. K. Kulp, D. Wang, C.-C. Yang, A. M. Sargeant, J.-H. Hung, Y. Kashida, M. Yamaguchi, G.-D. Chang, and C.-S. Chen Targeting Endoplasmic Reticulum Stress and Akt with OSU-03012 and Gefitinib or Erlotinib to Overcome Resistance to Epidermal Growth Factor Receptor Inhibitors Cancer Res., April 15, 2008; 68(8): 2820 - 2830. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. D. Bacolod, G. S. Schemmann, S. Wang, R. Shattock, S. F. Giardina, Z. Zeng, J. Shia, R. F. Stengel, N. Gerry, J. Hoh, et al. The Signatures of Autozygosity among Patients with Colorectal Cancer Cancer Res., April 15, 2008; 68(8): 2610 - 2621. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. P. Dhakal, B. Naume, M. Synnestvedt, E. Borgen, R. Kaaresen, E. Schlichting, G. Wiedswang, A. Bassarova, K.-E. Giercksky, and J. M. Nesland Vascularization in Primary Breast Carcinomas: Its Prognostic Significance and Relationship with Tumor Cell Dissemination Clin. Cancer Res., April 15, 2008; 14(8): 2341 - 2350. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Pavlova, M. Williams, A. El-Naggar, R. Richards-Kortum, and A. Gillenwater Understanding the Biological Basis of Autofluorescence Imaging for Oral Cancer Detection: High-Resolution Fluorescence Microscopy in Viable Tissue Clin. Cancer Res., April 15, 2008; 14(8): 2396 - 2404. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. X. Zhu and G. K. Abou-Alfa Expanding the Treatment Options for Hepatocellular Carcinoma: Combining Transarterial Chemoembolization With Radiofrequency Ablation JAMA, April 9, 2008; 299(14): 1716 - 1718. [Full Text] [PDF]
|
|
|
|
|
|
A. R. Giuliano and D. Salmon The Case for a Gender-Neutral (Universal) Human Papillomavirus Vaccination Policy in the United States: Point Cancer Epidemiol. Biomarkers Prev., April 1, 2008; 17(4): 805 - 808. [Full Text] [PDF]
|
|
|
|
|
|
M. J. Gunter, D. R. Hoover, H. Yu, S. Wassertheil-Smoller, J. E. Manson, J. Li, T. G. Harris, T. E. Rohan, X. Xue, G. Y.F. Ho, et al. A Prospective Evaluation of Insulin and Insulin-like Growth Factor-I as Risk Factors for Endometrial Cancer Cancer Epidemiol. Biomarkers Prev., April 1, 2008; 17(4): 921 - 929. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. B. Thomas, J. P. O'Beirne, J. Furuse, A. T. C. Chan, G. Abou-Alfa, and P. Johnson Systemic Therapy for Hepatocellular Carcinoma: Cytotoxic Chemotherapy, Targeted Therapy and Immunotherapy Ann. Surg. Oncol., April 1, 2008; 15(4): 1008 - 1014. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Krishnan, L. A. Dawson, J. Seong, Y. Akine, S. Beddar, T. M. Briere, C. H. Crane, and F. Mornex Radiotherapy for Hepatocellular Carcinoma: An Overview Ann. Surg. Oncol., April 1, 2008; 15(4): 1015 - 1024. [Full Text] [PDF]
|
|
|
|
 |
|
 J. W. Polli, J. E. Humphreys, K. A. Harmon, S. Castellino, M. J. O'Mara, K. L. Olson, L. St. John-Williams, K. M. Koch, and C. J. Serabjit-Singh The Role of Efflux and Uptake Transporters in N-{3-Chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine (GW572016, Lapatinib) Disposition and Drug Interactions Drug Metab. Dispos., April 1, 2008; 36(4): 695 - 701. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K.-i. Kozaki, I. Imoto, S. Mogi, K. Omura, and J. Inazawa Exploration of Tumor-Suppressive MicroRNAs Silenced by DNA Hypermethylation in Oral Cancer Cancer Res., April 1, 2008; 68(7): 2094 - 2105. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Yamashita, S. Takahashi, N. McDonell, N. Watanabe, T. Niwa, K. Hosoya, Y. Tsujino, T. Shirai, and T. Ushijima Methylation Silencing of Transforming Growth Factor-{beta} Receptor Type II in Rat Prostate Cancers Cancer Res., April 1, 2008; 68(7): 2112 - 2121. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. C. Fuchs, T. Fujii, J. D. Dorfman, J. M. Goodwin, A. X. Zhu, M. Lanuti, and K. K. Tanabe Epithelial-to-Mesenchymal Transition and Integrin-Linked Kinase Mediate Sensitivity to Epidermal Growth Factor Receptor Inhibition in Human Hepatoma Cells Cancer Res., April 1, 2008; 68(7): 2391 - 2399. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-M. Cho, T. Imai, Y. Ota, M. Hasumura, S. Takami, M. Hirose, and A. Nishikawa A New Medium-term Rat Colorectal Bioassay Applying Neoplastic Lesions as End Points for Detection of Carcinogenesis Modifiers Effects with Weak or Controversial Modifiers Toxicol Pathol, April 1, 2008; 36(3): 459 - 464. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Carlsten, G. S. Sagoo, A. J. Frodsham, W. Burke, and J. P. T. Higgins Glutathione S-Transferase M1 (GSTM1) Polymorphisms and Lung Cancer: A Literature-based Systematic HuGE Review and Meta-Analysis Am. J. Epidemiol., April 1, 2008; 167(7): 759 - 774. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Folprecht, M. T. Seymour, L. Saltz, J.-Y. Douillard, H. Hecker, R. J. Stephens, T. S. Maughan, E. Van Cutsem, P. Rougier, E. Mitry, et al. Irinotecan/Fluorouracil Combination in First-Line Therapy of Older and Younger Patients With Metastatic Colorectal Cancer: Combined Analysis of 2,691 Patients in Randomized Controlled Trials J. Clin. Oncol., March 20, 2008; 26(9): 1443 - 1451. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. K. Hoang, L. F. Hoagland, R. E. Coleman, A. D. Coan, J. E. Herndon II, and E. F. Patz Jr Prognostic Value of Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography Imaging in Patients With Advanced-Stage Non-Small-Cell Lung Carcinoma J. Clin. Oncol., March 20, 2008; 26(9): 1459 - 1464. [Abstract] [Full Text] [PDF]
|
|
| < |
